As of April 16, 2025, JD Health (6618.HK) has a market cap of $14.35 billion USD. According to our data, JD Health is ranked No.1211 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $14.35 B |
23.23%
|
Dec 31, 2024 | $11.65 B |
-27.75%
|
Dec 29, 2023 | $16.12 B |
-45.20%
|
Dec 30, 2022 | $29.42 B |
15.45%
|
Dec 31, 2021 | $25.48 B |
-58.52%
|
Dec 31, 2020 | $61.44 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Alibaba Health Information Technology
0241.HK
|
$9.36 B |
-0.166 B
|
![]() Hong Kong
|
![]() 111, Inc.
YI
|
$65.10 M |
27.360 M
|
![]() China
|
![]() China Resources Pharmaceutical Group
3320.HK
|
$3.93 B |
-0.089 B
|
![]() Hong Kong
|
![]() Sinopharm
1099.HK
|
$3.04 B |
-0.062 B
|
![]() China
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
Market Cap | = | 6618.HK Stock Price | * | 6618.HK Shares Outstanding |
= | $4.49 | * | 3.20 B | |
= | $14.35 B |